The dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist tirzepatide: a novel cardiometabolic therapeutic prospect

Incretin hormones are peptides released in the intestine in response to the presence of nutrients in its lumen. The main incretins are glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP). GLP-1 stimulates insulin secretion, inhibits glucagon secretion at pancreatic...

Descripción completa

Detalles Bibliográficos
Autores principales: Fisman, Enrique Z., Tenenbaum, Alexander
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613929/
https://www.ncbi.nlm.nih.gov/pubmed/34819089
http://dx.doi.org/10.1186/s12933-021-01412-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8613929/
https://www.ncbi.nlm.nih.gov/pubmed/34819089
http://dx.doi.org/10.1186/s12933-021-01412-5

Ejemplares similares